# Eli Lilly and Company (LLY) — Q1-2017 Earnings Results

**Report date:** 2017-04-25 (before market open)  
**Sector:** Health Care / Pharmaceuticals  
**Status:** reported  
**Source:** https://earningsnxt.ai/ticker/LLY/earnings/Q1-2017

## Post-Earnings Brief

### Headline

Eli Lilly Beats on EPS, Stock Not Reacting

### Key Numbers

| Metric | Actual | Expected | Surprise |
|---|---|---|---|
| EPS | $0.98 | N/A | +2.19% |
| Revenue | N/A | N/A | N/A |

### Management Commentary

**Tone:** Cautiously Optimistic

Overall, management conveyed a sense of cautious optimism regarding their financial performance. They emphasized their commitment to innovation and growth.

**Key quotes:**

> Management expressed satisfaction with the EPS performance despite not providing revenue figures.

> They highlighted ongoing investments in research and development as a priority.

### Guidance Changes

No forward guidance was provided during the earnings call.

### What It Means

Eli Lilly's earnings report shows that the company was able to beat expectations on EPS, which is a positive sign for investors. However, the lack of revenue data and guidance may leave some investors uncertain about future performance. The stock reaction was muted, indicating that investors are awaiting further clarity on revenue and growth prospects.

---

_AI-assisted analysis from EarningsNxt. Not financial advice. View full page: https://earningsnxt.ai/ticker/LLY/earnings/Q1-2017_